Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Virology

DNA from BK Virus and JC Virus and from KI, WU, and MC Polyomaviruses as Well as from Simian Virus 40 Is Not Detected in Non-UV-Light-Associated Primary Malignant Melanomas of Mucous Membranes

Géraldine Giraud, Torbjörn Ramqvist, Boel Ragnarsson-Olding, Tina Dalianis
Géraldine Giraud
Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: geraldine.giraud@ki.se
Torbjörn Ramqvist
Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Boel Ragnarsson-Olding
Department of Oncology-Pathology, Karolinska Institutet, Cancer Center KarolinskaDepartment of Oncology, Radiumhemmet, Karolinska University Hospital, SE-171 76 Stockholm
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tina Dalianis
Department of Oncology-Pathology, Karolinska Institutet, Cancer Center KarolinskaDepartment of Virology, Swedish Institute for Infectious Disease Control, 171 82 Solna, Sweden
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.01635-08
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article has a correction. Please see:

  • DNA from BK Virus and JC Virus and from KI, WU, and MC Polyomaviruses as Well as from Simian Virus 40 Is Not Detected in Non-UV-Light-Associated Primary Malignant Melanomas of Mucous Membranes - August 31, 2009

ABSTRACT

The single most important causative factor for malignant melanomas of the skin is UV radiation. However, this is not true for melanomas on body surfaces sheltered from the sun; thus, it is important to seek new causative factors of melanoma genesis. Human papillomaviruses and gammaherpesviruses are associated with human skin cancer; for example, human papillomavirus types 5 and 8 are associated with epidermodysplasia verruciformis, and human herpesvirus 8 is associated with Kaposi's sarcoma. Recently, a newly described human polyomavirus, Merkel cell polyomavirus (MCPyV), has been associated with Merkel cell carcinoma, an unusual form of neurotropic skin cancer. Moreover, melanocytes are of neuroepithelial origin. This background impelled us to investigate if human polyomavirus DNA could play a role in the development of extracutaneous melanomas. Sixty-four extracutaneous melanomas were initially collected and dissected. Of these, 38 could be successfully used for further testing for the presence of the five human polyomaviruses known so far—BK virus (BKV), JC virus (JCV), KI polyomavirus (KIPyV), WU polyomavirus (WUPyV), and MCPyV—and of simian virus 40 (SV40). No polyomavirus DNA could be detected in any of the samples tested by use of a nested PCR detecting BKV, JCV, and SV40; a newly designed PCR detecting KIPyV and WUPyV; or a newly designed PCR for MCPyV. We conclude that since no human polyomavirus DNA was detected in primary malignant melanomas on non-sun-exposed body surfaces, these polyomaviruses presumably are not major factors for the development of extracutaneous melanomas.

The single most important factor for the development of malignant melanomas of the skin is UV radiation. In addition, numerous other risk factors or cofactors have been demonstrated, such as, e.g., hereditary/familial predisposition, a large number of nevi, the skin phenotype, and the hair and eye colors (13). However, UV radiation presumably cannot be responsible for some subgroups of cutaneous melanomas on body surfaces more or less sheltered from the sun, such as the acral lentiginous melanomas of the palms, soles, and subungual areas. Moreover, melanomas can appear on body surfaces completely sheltered from the sun, e.g., mucosal membranes of the sinonasal cavity, the anus-rectum, the vulva-vagina, and the penis. These melanomas, sometimes named extracutaneous melanomas, are rare in absolute numbers compared to the cutaneous melanomas but are similar to them if density (i.e., the average number of tumors per square unit of body surface area) is taken into account (19). This similarity in melanoma density is compelling and demonstrates the necessity of finding new causative factors of melanoma genesis. Nevertheless, there are biological differences between cutaneous and extracutaneous melanomas, and it is possible that by comparing extracutaneous melanomas with cutaneous melanomas, we may find non-UV-light-associated factors or cofactors in melanoma genesis. Viruses could be such factors. It is possible that DNA viruses are associated with melanoma genesis, even if this is extremely difficult to demonstrate. In previous reports, we have investigated whether human papillomavirus (HPV) or any of the eight viruses of the human herpesvirus group were present in more than 40 extracutaneous melanomas. No HPV DNA-positive melanoma was detected, although different general primers and several type-specific primers were used, and only two herpesvirus-positive melanomas were detected, indicating that neither HPV nor viruses of the herpesvirus family are major etiological agents for extracutaneous melanomas (7, 15).

In the present study, we were particularly interested in exploring the possible presence in extracutaneous melanomas of the five presently known members of the human polyomavirus family and simian virus 40 (SV40), since some of these viruses are potentially neurotropic and melanocytes have a neuroepithelial origin. Since their discovery in 1971, BK virus (BKV) and JC virus (JCV) (10, 18) had been the only known human polyomaviruses; last year, however, two new human viruses, KI polyomavirus (KIPyV) and WU polyomavirus (WUPyV), were identified (2, 11). In addition, more recently, a fifth human polyomavirus has been identified in several cases of Merkel cell carcinoma, a rare malignancy of the skin; this virus was therefore named Merkel cell polyomavirus (MCPyV) (9). While KIPyV and WUPyV have not yet been linked to any disease, MCPyV has been suggested to be a contributing factor in the pathogenesis of Merkel cell carcinoma (9). Polyomaviruses are generally species specific, and as mentioned above, five have been described as human polyomaviruses (23). However, in addition to these five, a sixth polyomavirus, SV40, from the rhesus monkey, has, to a variable but generally rare extent, been detected in humans (3). Both BKV and JCV establish latency after primary infection and can be reactivated under certain circumstances (21). Seroprevalence (in Sweden) ranges from 70 to 80% for both BKV and JCV but is not known for the newly detected human polyomaviruses. However, several studies have found KIPyV, as well as WUPyV, in 1 to 3% of nasopharyngeal aspirates from children (2, 4, 11, 17). Moreover, in one report, as many as 6% of nasopharyngeal aspirates from healthy children were positive for WUPyV (1).

In the present study, we aimed to investigate whether human polyomaviruses could be detected in melanomas from non-sun-exposed body areas and whether they could possibly be considered causative agents in the genesis of some melanomas. For this purpose, more than 30 formalin-fixed extracutaneous melanoma samples were examined for the presence of human polyomavirus DNA.

MATERIALS AND METHODS

Patients' tumor material.Thirty-eight mucosal melanoma samples with confirmed PCR-amplifiable DNA tested in two previous studies (7, 15) were selected from samples from 64 patients who were diagnosed from 1985 to 2003 and reported to the (compulsory) Swedish Cancer Registry. The present study was conducted with the permission of the Swedish Data Inspection Authority and the Human Ethical Committee at the Karolinska Institutet and was in compliance with their rules. All histological slides were reviewed, and only primary melanomas, not metastases, were used for further analysis.

Preparation of samples.One 4-μm-thick and two 20-μm-thick consecutive sections were cut from each paraffin block of formalin-fixed tissue. The 4-μm sections were stained with hematoxylin and eosin to guide the dissection of tumor tissue to be used for DNA analysis. Tumor tissues were dissected with a scalpel under light microscopy in each case in order to avoid potential contamination with virus from surrounding tissues and from heavily inflammatory cell infiltrates. This procedure resulted in approximately 90% pure tumor samples for further analysis. Similarly, microtome knives and scalpels were washed in 70% ethanol between each preparation, and each section was stretched on a drop of distilled water placed on each slide, instead of using a regular water bath, in order to avoid contamination. In seven cases, the whole biopsy specimen contained tumor tissue and further dissection was not necessary.

DNA extraction.DNA was extracted using the High Pure RNA extraction kit (Roche Diagnostics GmbH, Mannheim, Germany) according to the manufacturer's protocol, but without DNase treatment. Briefly, the paraffin was removed by treatment with xylene and ethanol. The tissue pellet was disrupted by overnight incubation at 55°C in tissue lysis buffer with the addition of sodium dodecyl sulfate and proteinase K. On day 2, the DNA was bound to a membrane in collection tubes, washed, and eluted by elution buffer. The proteinase K treatment was repeated once (incubation for 1 h at 55°C) for the removal of trace proteins. The DNA was bound to the membrane in a fresh collection tube, washed, and eluted, and finally the DNA amount and purity were measured by NanoDrop technology (NanoDrop Technology Inc., Wilmington, DE). To avoid and check for virus carryover between the melanoma samples, tubes with a slice from an empty paraffin block were placed between the samples and treated in the same way as the melanoma samples throughout the experimental procedures.

Verification of amplifiable DNA.To avoid false-negative results due to DNA unsuitable for PCR analysis, a control PCR with β-microglobulin primers was run in 100 to 120 ng DNA for all samples in a previous study (7).

Nested PCR for the detection of BKV, JCV, and SV40.To detect the presence of BKV, JCV, or SV40, a nested PCR was performed as described previously (5, 12). In addition, each reaction tube contained 0.4 μg/μl purified bovine serum albumin (BSA) to avoid possible inhibition of the PCR by a high concentration of melanin in the DNA extracts. A urine sample positive for BKV, used as a positive control, was kindly provided by Anna-Lena Hammarin (SMI, Karolinska Institutet, Stockholm, Sweden).

PCR assay for the detection of KIPyV and WUPyV.To simultaneously detect the presence of KIPyV and WUPyV, a standard PCR was performed with a single primer pair detecting part of the VP1 region of both viruses (Table 1). The reverse primer KIPyV2404.R had a length of 27 bases to compensate for one mismatch with the WUPyV sequence at base 20. The 50-μl reaction mixture consisted of 50 mM NaCl, 10 mM Tris-HCl (pH 8.3), 3 mM MgCl2, 200 μM of each deoxynucleoside triphosphate, 1 U of Taq DNA polymerase, 0.3 μM of each primer, and 500 to 1,000 ng of amplifiable DNA, corresponding to 1 × 105 to 2 × 105 cells per reaction. In addition, each reaction mixture contained 0.4 μg/μl purified BSA to prevent possible inhibition of the PCR by a high concentration of melanin in the DNA extracts. An initial 1-min denaturation at 94°C was followed by 40 cycles of 30 s at 94°C, 30 s at 53°C, and 45 s at 72°C, which, in turn, were followed by a final step of 5 min at 72°C. To produce a positive control, KIPyV bp 1395 to 2159 was cloned into pBSKS.

View this table:
  • View inline
  • View popup
TABLE 1.

Sequences of primers used in PCRs for detection of BKV, JCV, and SV40, KIPyV and WUPyV, and MCPyV

PCR assay for the detection of MCPyV.To detect the presence of MCPyV, a standard PCR was performed with a primer pair detecting part of the large T (LT) region of MCPyV (Table 1). The 50-μl reaction mixture consisted of 50 mM NaCl, 10 mM Tris-HCl (pH 8.3), 3 mM MgCl2, 200 μM of each deoxynucleoside triphosphate, 1 U of Taq DNA polymerase, 0.3 μM of each primer, and 500 to 1,000 ng of amplifiable DNA, corresponding to 1 × 105 to 2 × 105 cells per reaction. In addition, each reaction tube contained 0.4 μg/μl purified BSA to prevent possible inhibition of the PCR by a high concentration of melanin in the DNA extracts. An initial 1-min denaturation at 94°C was followed by 40 cycles of 30 s at 94°C, 30 s at 53°C, and 45 s at 72°C, with a final step for 5 min at 72°C. Plasmid pUC57MC1, containing MCPyV bp 1681 to 1870 (constructed upon request by GenScript Corporation), was used as a positive control.

Evaluation of the sensitivities of the KIPyV and WUPyV PCR assay and the MCPyV PCR assay.To define the detection levels of the two newly designed PCR assays for KIPyV, WUPyV, and MCPyV, the assays were performed with increasing concentrations of the respective plasmids, from 5 copies to 1 billion copies. In order to investigate if there was any inhibiting effect of genomic DNA on PCR sensitivity, the detection level was also evaluated with 100 ng, 500 ng, and 1,000 ng of genomic DNA.

RESULTS AND DISCUSSION

To simultaneously assay for the presence of the two related polyomaviruses, KIPyV and WUPyV, a PCR assay utilizing primers directed at identical or nearly identical sequences in the two viruses was established (Table 1). The resulting amplicon had a size of 142 bp, and as few as 10 copies of a plasmid containing the KIPyV VP1 gene could be detected consistently and reliably. The detection limit remained unchanged when genomic DNA was added to the assay (data not shown). In addition, to assay for the presence in melanomas of the early region of MCPyV, a PCR assay utilizing primers detecting the central part of the LT antigen open reading frame was established (Table 1). This assay generated an amplicon of 138 bp, and 1,000 copies of plasmid pUC57MC1, containing this part of LT, could consistently be detected. The detection level was unaffected when pUC57MC1 was mixed with genomic DNA (data not shown). The two new methods for the detection of KIPyV, WUPyV, and MCPyC were highly sensitive—comparable in sensitivity to the nested PCR for BKV, JCV, and SV40—enabling us to assay for all six polyomaviruses with similar sensitivities.

Sixty-four patients diagnosed with melanomas of the mucous membranes from 1985 to 2003 were initially included in the study. For technical reasons, mainly because of a shortage of tumor tissues in the paraffin blocks, only 38 cases, previously confirmed to have amplifiable DNA (7), were further analyzed for the presence of BKV, JCV, and SV40 DNA. Of these 38 samples, 37 could also be tested for MCPyV and 36 for KIPyV and WUPyV. The sites of these 38 melanomas were as follows: anal canal, 12; anus-rectum, 4; nasal cavity, 6; vulva, 6; vagina-cervix, 4; tongue, 1; penis, 1; subungual site, 2; skin, 1; oral cavity, 1. Due to the shortage of some nasal cavity samples, one could not be tested for MCPyV and two others could not be tested for KIPyV and WUPyV. No polyomavirus DNA could be detected in any of the samples by using a nested PCR detecting BKV, JCV, and SV40 or the two newly designed PCR assays, detecting KIPyV and WUPyV or MCPyV, respectively.

To our knowledge, this is the first time the possible presence of polyomaviruses in melanomas was examined, and since melanocytes have a neuroepithelial origin, the possibility was that, e.g., JCV DNA could have been detected in these tumors. Moreover, among the human polyomavirus family, JCV is associated with the growth of glial cells in cases of progressive multifocal leukoencephalopathy. In addition, in several reports, JCV has been detected in a variety of brain tumors, in central nervous system lymphomas, and in colorectal tumors. No causal role of JCV in neoplasia has been established yet (14). Nonetheless, it is clear that BKV, JCV, and SV40 can cause cancer in laboratory animals (23), and the report that transgenic mice expressing the SV40 LT antigen in pigment cells can develop melanomas (16) is of specific interest in this context. Furthermore, important steps in neoplastic transformation have been documented for some of the polyomaviruses discussed above, involving the inactivation of p53 and pRb by the binding of the large T antigens of different polyomaviruses to these proteins (6, 8). Notably, extracutaneous melanomas show a higher frequency of silent mutations in the p53 gene than cutaneous melanomas (20), which may suggest genomic instability (22). The hypothesis of genetic instability triggered by the interaction of the large T antigen and p53 led us to consider the role of polyomaviruses in the development of extracutaneous melanomas.

In this study, none of the 38 patient samples tested positive for any of the five human polyomaviruses tested or for SV40, although the methods used in this study had high sensitivity. This argues against the possibility that human polyomaviruses are causative agents of non-UV-light-associated melanomas.

The development of two newly designed PCRs remains interesting for further studies. The regular PCR detecting both KIPyV and WUPyV is highly sensitive and requires less material to test than two distinct PCRs. The regular PCR detecting MCPyV is also highly sensitive and has the advantage of detecting the large T region; thus, it can still detect a truncated virus lacking parts of the late region, which could be the case in the genesis of tumor development.

In conclusion, the present investigation suggests that neither any of the five human polyomaviruses known so far—BKV, JCV, KIPyV, WUPyV, and MCPyV—nor SV40 is involved in the development of extracutaneous melanomas.

ACKNOWLEDGMENTS

We thank Kalle Andreasson, Rainer Tuominen (Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Stockholm, Sweden) and Tobias Allander (Laboratory for Clinical Microbiology, Department of Microbiology, Tumor and Cell Biology, Karolinska University Hospital, Stockholm, Sweden) for valuable advice and technical assistance.

This investigation was supported financially by the Swedish Research Council (VR), The Swedish Cancer Foundation, The Stockholm City Council, Karolinska Institutet, King Gustav V's Jubilee Fund, The Stockholm Cancer Society, and the Children's Cancer Foundation.

FOOTNOTES

    • Received 22 August 2008.
    • Accepted 22 August 2008.
  • ↵▿ Published ahead of print on 3 September 2008.

  • American Society for Microbiology

REFERENCES

  1. 1.↵
    Abed, Y., D. Wang, and G. Boivin. 2007. WU polyomavirus in children, Canada. Emerg. Infect. Dis. 13:1939-1941.
    OpenUrlPubMed
  2. 2.↵
    Allander, T., K. Andreasson, S. Gupta, A. Bjerkner, G. Bogdanovic, M. A. Persson, T. Dalianis, T. Ramqvist, and B. Andersson. 2007. Identification of a third human polyomavirus. J. Virol. 81:4130-4136.
    OpenUrlAbstract/FREE Full Text
  3. 2a.
    Arthur, R. R., S. Dagostin, and K. V. Shah. 1989. Detection of BK virus and JC virus in urine and brain tissue by the polymerase chain reaction. J. Clin. Microbiol. 27:1174-1179.
    OpenUrlAbstract/FREE Full Text
  4. 3.↵
    Barbanti-Brodano, G., S. Sabbioni, F. Martini, M. Negrini, A. Corallini, and M. Tognon. 2006. BK virus, JC virus and simian virus 40 infection in humans, and association with human tumors. Adv. Exp. Med. Biol. 577:319-341.
    OpenUrlCrossRefPubMed
  5. 4.↵
    Bialasiewicz, S., D. M. Whiley, S. B. Lambert, D. Wang, M. D. Nissen, and T. P. Sloots. 2007. A newly reported human polyomavirus, KI virus, is present in the respiratory tract of Australian children. J. Clin. Virol. 40:15-18.
    OpenUrlCrossRefPubMedWeb of Science
  6. 5.↵
    Bogdanovic, G., M. Brytting, P. Cinque, M. Grandien, E. Fridell, P. Ljungman, B. Lönnqvist, and A. L. Hammarin. 1994. Nested PCR for detection of BK virus and JC virus DNA. Clin. Diagn. Virol. 2:211-220.
    OpenUrlCrossRefPubMed
  7. 6.↵
    Carbone, M., P. Rizzo, P. M. Grimley, A. Procopio, D. J. Mew, V. Shridhar, A. de Bartolomeis, V. Esposito, M. T. Giuliano, S. M. Steinberg, A. S. Levine, A. Giordano, and H. I. Pass. 1997. Simian virus-40 large-T antigen binds p53 in human mesotheliomas. Nat. Med. 3:908-912.
    OpenUrlCrossRefPubMedWeb of Science
  8. 7.↵
    Dahlgren, L., K. Schedvins, L. R. Kanter-Lewensohn, T. Dalianis, and B. K. Ragnarsson-Olding. 2005. Human papilloma virus (HPV) is rarely detected in malignant melanomas of sun sheltered mucosal membranes. Acta Oncol. 44:694-699.
    OpenUrlCrossRefPubMed
  9. 8.↵
    Dyson, N., R. Bernards, S. H. Friend, L. R. Gooding, J. A. Hassell, E. O. Major, J. M. Pipas, T. Vandyke, and E. Harlow. 1990. Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J. Virol. 64:1353-1356.
    OpenUrlAbstract/FREE Full Text
  10. 9.↵
    Feng, H., M. Shuda, Y. Chang, and P. S. Moore. 2008. Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096-1100.
    OpenUrlAbstract/FREE Full Text
  11. 9a.
    Frisque, R. J., G. L. Bream, and M. T. Cannella. 1984. Human polyomavirus JC virus genome. J. Virol. 51:458-469.
    OpenUrlAbstract/FREE Full Text
  12. 10.↵
    Gardner, S. D., A. M. Field, D. V. Coleman, and B. Hulme. 1971. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet i:1253-1257.
  13. 11.↵
    Gaynor, A., M. D. Nissen, D. M. Whiley, I. M. Mackay, S. B. Lambert, G. Wu, D. C. Brennan, G. A. Storch, T. P. Sloots, and D. Wang. 2007. Identification of a novel polyomavirus from patients with acute respiratory tract infections. PLoS Pathog. 3:e64.
    OpenUrlCrossRefPubMed
  14. 12.↵
    Hammarin, A. L., G. Bogdanovic, V. Svedhem, R. Pirskanen, L. Morfeldt, and M. Grandien. 1996. Analysis of PCR as a tool for detection of JC virus DNA in cerebrospinal fluid for diagnosis of progressive multifocal leukoencephalopathy. J. Clin. Microbiol. 34:2929-2932.
    OpenUrlAbstract/FREE Full Text
  15. 13.↵
    Holman, C. D., and B. K. Armstrong. 1984. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma. JNCI 72:257-266.
    OpenUrlPubMedWeb of Science
  16. 14.↵
    Khalili, K., J. Gordon, and M. K. White. 2006. The polyomavirus, JCV and its involvement in human disease. Adv. Exp. Med. Biol. 577:274-287.
    OpenUrlCrossRefPubMedWeb of Science
  17. 15.↵
    Lundberg, R., M. Brytting, L. Dahlgren, L. R. Kanter-Lewensohn, L. Schloss, T. Dalianis, and B. K. Ragnarsson-Olding. 2006. Human herpes virus DNA is rarely detected in non-UV light-associated primary malignant melanomas of mucous membranes. Anticancer Res. 26:3627-3631.
    OpenUrlAbstract/FREE Full Text
  18. 16.↵
    Mintz, B., W. K. Silvers, and A. J. P. Klein-Szanto. 1993. Histopathogenesis of malignant skin melanoma induced in genetically susceptible transgenic mice. Proc. Natl. Acad. Sci. USA 90:8822-8826.
    OpenUrlAbstract/FREE Full Text
  19. 17.↵
    Norja, P., I. Ubillos, K. Templeton, and P. Simmonds. 2007. No evidence for an association between infections with WU and KI polyomaviruses and respiratory disease. J. Clin. Virol. 40:307-311.
    OpenUrlCrossRefPubMedWeb of Science
  20. 18.↵
    Padgett, B., D. L. Walker, G. M. ZuRhein, R. J. Eckroade, and B. H. Dessel. 1971. Cultivation of papova-like virus from human brain with progressive multifocal leucoencephalopathy. Lancet i:1257-1260.
  21. 19.↵
    Ragnarsson-Olding, B. K., L. R. Kanter-Lewensohn, B. Lagerlöf, B. R. Nilsson, and U. K. Ringborg. 1999. Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females: clinical observations and histopathologic features. Cancer 86:1273-1284.
    OpenUrlCrossRefPubMedWeb of Science
  22. 20.↵
    Ragnarsson-Olding, B. K., S. Karsberg, A. Platz, and U. K. Ringborg. 2002. Mutations in the TP53 gene in human malignant melanomas derived from sun-exposed skin and unexposed mucosal membranes. Melanoma Res. 12:453-463.
    OpenUrlCrossRefPubMedWeb of Science
  23. 21.↵
    Randhawa, P., A. Vats, and R. Shapiro. 2006. The pathobiology of polyomavirus infection in man. Adv. Exp. Med. Biol. 577:148-159.
    OpenUrlPubMed
  24. 22.↵
    Strauss, B. S. 1999. Frameshift mutation, microsatellites and mismatch repair. Mutat. Res. 437:195-203.
    OpenUrlCrossRefPubMedWeb of Science
  25. 23.↵
    White, M. K., J. Gordon, K. Reiss, L. Del Valle, S. Croul, A. Giordano, A. Darbinyan, and K. Khalili. 2005. Human polyomaviruses and brain tumors. Brain Res. Rev. 50:69-85.
    OpenUrlPubMed
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
DNA from BK Virus and JC Virus and from KI, WU, and MC Polyomaviruses as Well as from Simian Virus 40 Is Not Detected in Non-UV-Light-Associated Primary Malignant Melanomas of Mucous Membranes
Géraldine Giraud, Torbjörn Ramqvist, Boel Ragnarsson-Olding, Tina Dalianis
Journal of Clinical Microbiology Oct 2008, 46 (11) 3595-3598; DOI: 10.1128/JCM.01635-08

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
DNA from BK Virus and JC Virus and from KI, WU, and MC Polyomaviruses as Well as from Simian Virus 40 Is Not Detected in Non-UV-Light-Associated Primary Malignant Melanomas of Mucous Membranes
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
Share
DNA from BK Virus and JC Virus and from KI, WU, and MC Polyomaviruses as Well as from Simian Virus 40 Is Not Detected in Non-UV-Light-Associated Primary Malignant Melanomas of Mucous Membranes
Géraldine Giraud, Torbjörn Ramqvist, Boel Ragnarsson-Olding, Tina Dalianis
Journal of Clinical Microbiology Oct 2008, 46 (11) 3595-3598; DOI: 10.1128/JCM.01635-08
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS AND DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

Copyright © 2019 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X